文献速递胰腺与胆道疾病消化内镜

加速与阶梯式内镜治疗胰腺包裹性坏死的随机对照试验

Accelerated vs Step-Up Endoscopic Treatment for Pancreatic Walled-Off Necrosis: A Randomized Controlled Trial (ACCELERATE).
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-08-18

这项单中心开放标签随机对照试验在丹麦纳入25例WON>15 cm患者,因阶梯组安全顾虑提前终止。

要点

  • 加速方案可能降低WON>15 cm患者重大并发症风险。
  • 加速方案可能缩短中位住院时间(32.5天 vs 68.5天)。
  • 试验因阶梯组安全顾虑提前终止,样本仅25例。

核心结论

  • 与阶梯式方案相比,加速治疗流程可能显著降低WON>15 cm患者重大并发症风险、住院时间和炎症负荷。

研究设计与样本

  • 单中心、开放标签、随机对照试验,在丹麦三级医疗中心开展,纳入WON>15 cm患者25例(加速组12例,阶梯组13例),因阶梯组安全顾虑提前终止。

临床怎么用

  • 对WON>15 cm患者,可考虑采用加速内镜治疗流程(初次操作即行坏死清除术并按需重复),以降低重大并发症和缩短住院时间。

局限性

  • 单中心、开放标签设计,样本量仅25例,且试验因安全顾虑提前终止,结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoscopic step-up treatment with ultrasound-guided drainage and necrosectomy has become the gold standard treatment of pancreatic walled-off necrosis (WON); however, the length of stay (LOS) in hospital of patients with large WON remains substantial. We hypothesized that an accelerated treatment protocol could reduce LOS and major complications in patients with large WON. METHODS: This single-center, open-label, randomized controlled trial conducted at a tertiary care facility in Denmark included patients with WON >15 cm, randomized to either an accelerated or step-up treatment approach. In the accelerated group, necrosectomy was performed during the index procedure and repeated as needed. In the step-up group, necrosectomy was only performed in cases without clinical improvement. The primary composite endpoints were death, major complications, and LOS >58 days. RESULTS: The trial, which was prematurely terminated due to concerns for the safety of the patients in the step-up group based on a benefit-to-risk assessment, included 25 patients (12 accelerated, 13 step-up). Baseline characteristics were comparable between groups. The primary composite outcome occurred in 8.3% of patients in the accelerated group vs 61.5% in the step-up group (absolute risk reduction, 53.5%; relative risk, 0.14; P = .011). Major complications occurred less frequently in the accelerated group (0.0% vs 46.2%; P = .015), and the median LOS was shorter (32.5 days; interquartile range, 17.5-38.2 days vs 68.5 days; interquartile range, 35.5-97.8 days; P = .039). CONCLUSIONS: An accelerated treatment protocol may significantly reduce the risk of major complications, LOS, and inflammatory burden compared with a step-up approach, suggesting its adoption in treatment large WON. CLINICALTRIALS: gov, Number: NCT05601687.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Olsen GA, Schmidt PN, Hadi A, et al. Accelerated vs Step-Up Endoscopic Treatment for Pancreatic Walled-Off Necrosis: A Randomized Controlled Trial (ACCELERATE). Clin Gastroenterol Hepatol. 2025. PMID: 40835042. doi:10.1016/j.cgh.2025.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。